The Change of focal macular electroretinogram(ERG) in patients with age-related macular degeneration after intravitreal aflibercept(IVA).
Phase 4
- Conditions
- Age-related macular degeneration
- Registration Number
- JPRN-UMIN000023590
- Lead Sponsor
- Dokkyo Medical University, Koshigaya Hospital Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with any previous history of treatment of other retinal diseases with pharmacologic agents including verteporfin photodynamic therapy, aflibercept, ranibizumab, bevacizumab or steroids. 2) Clinically significant drug allergy. 3) History of vitrectomy or glaucoma surgery. 4) Presence of RPE tears, angoid streaks or pathologic myopia. 5) Concomitant conditions/diseases including uncontrolled glaucoma and intraocular inflammation 6) Patients who the doctor in charge judges are ineligible for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method